Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 67
Filter
1.
J Sci Food Agric ; 98(9): 3225-3233, 2018 Jul.
Article in English | MEDLINE | ID: mdl-29280151

ABSTRACT

Pyrraline and pentosidine are advanced Maillard reaction products derived from the reaction of glucose with the lysine amino group on proteins. They have been implicated in uremia, diabetes, and related complications, including inflammation, retinopathy, and nephropathy. This review focuses on the formation mechanism, human potential risks, and detections of pentosidine and pyrraline and lays the foundation for further study of pentosidine and pyrraline. © 2017 Society of Chemical Industry.


Subject(s)
Arginine/analogs & derivatives , Food Analysis , Lysine/analogs & derivatives , Norleucine/analogs & derivatives , Pyrroles/adverse effects , Pyrroles/analysis , Arginine/adverse effects , Arginine/analysis , Arginine/chemistry , Cross-Linking Reagents , Diabetes Complications/chemically induced , Diabetes Mellitus/chemically induced , Glucose/chemistry , Glycation End Products, Advanced , Humans , Inflammation/chemically induced , Lysine/adverse effects , Lysine/analysis , Lysine/chemistry , Molecular Structure , Norleucine/adverse effects , Norleucine/analysis , Norleucine/chemistry , Pyrroles/chemistry , Risk Factors , Uremia/chemically induced
2.
Chembiochem ; 18(3): 266-275, 2017 02 01.
Article in English | MEDLINE | ID: mdl-27900834

ABSTRACT

The yeast Saccharomyces cerevisiae transforms branched-chain and aromatic amino acids into higher alcohols in the Ehrlich pathway. During microbiological culturing and industrial fermentations, this yeast is confronted with amino acids modified by reducing sugars in the Maillard reaction (glycation). In order to gain some preliminary insight into the physiological "handling" of glycated amino acids by yeasts, individual Maillard reaction products (MRPs: fructosyllysine, carboxymethyllysine, pyrraline, formyline, maltosine, methylglyoxal-derived hydroimidazolone) were administered to two strains of S. cerevisiae in a rich medium. Only formyline was converted into the corresponding α-hydroxy acid, to a small extent (10 %). Dipeptide-bound pyrraline and maltosine were removed from the medium with concomitant emergence of several metabolites. Pyrraline was mainly converted into the corresponding Ehrlich alcohol (20-60 %) and maltosine into the corresponding α-hydroxy acid (40-60 %). Five specific metabolites of glycated amino acids were synthesized and characterized. We show for the first time that S. cerevisiae can use glycated amino acids as a nitrogen source and transform them into new metabolites, provided that the substances can be transported across the cell membrane.


Subject(s)
Amino Acids/metabolism , Dipeptides/metabolism , Saccharomyces cerevisiae/metabolism , Amino Acids/chemistry , Chromatography, High Pressure Liquid , Chromatography, Reverse-Phase , Dipeptides/chemistry , Glycosylation , Maillard Reaction , Norleucine/analogs & derivatives , Norleucine/analysis , Norleucine/metabolism , Protein Stability , Pyridones/analysis , Pyridones/metabolism , Pyrroles/analysis , Pyrroles/metabolism , Spectrophotometry, Infrared , Tandem Mass Spectrometry
3.
Amino Acids ; 44(4): 1225-31, 2013 Apr.
Article in English | MEDLINE | ID: mdl-23306451

ABSTRACT

In this study, a precise and reliable ultra-high performance liquid chromatography (UHPLC) method for the simultaneous determination of non-canonical (norvaline and norleucine) and standard amino acids (aspartic acid, glutamic acid, serine, histidine, glycine, threonine, arginine, tyrosine, methionine, valine, phenylalanine, isoleucine, leucine) in biopharmaceutical-related fermentation processes was established. After pre-column derivatization with ortho-phthaldialdehyde and 2-mercaptoethanol, the derivatives were separated on a sub-2 µm particle C18 reverse-phase column. Identification and quantification of amino acids were carried out by fluorescence detection. To test method feasibility on standard HPLC instruments, the assay was properly transferred to a core-shell particle C18 reverse-phase column. The limits of detection showed excellent sensitivity by values from 0.06 to 0.17 pmol per injection and limits of quantification between 0.19 and 0.89 pmol. In the present study, the newly established UHPLC method was applied to a recombinant antibody Escherichia coli fermentation process for the analysis of total free amino acids. We were able to specifically detect and quantify the unfavorable amino acids in such complex samples. Since we observed trace amounts of norvaline and norleucine during all fermentation phases, an obligatory process monitoring should be considered to improve quality of recombinant protein drugs in future.


Subject(s)
Antibodies/metabolism , Chromatography, High Pressure Liquid/methods , Norleucine/analysis , Valine/analogs & derivatives , Antibodies/genetics , Escherichia coli/chemistry , Escherichia coli/genetics , Fermentation , Industrial Microbiology , Norleucine/metabolism , Valine/analysis , Valine/metabolism
4.
Food Chem ; 314: 126176, 2020 Jun 01.
Article in English | MEDLINE | ID: mdl-31962282

ABSTRACT

Pasteurized donor human milk (PDHM) for preterm infant nutrition is fortified with hydrolyzates of cow's milk proteins, which have been poorly investigated in relation to heat-damage and occurrence of the bioactive peptides ß-casomorphins (BCMs). Therefore, thermal protein modifications of three commercial fortifiers were assessed by measuring well-recognized indexes of heat load. The fortifiers did not contain pyrraline, whereas furosine and lysinoalanine levels roughly overlapped the lowest values reported for liquid formulas addressed to term infant nutrition. Bovine BCMs 3 to 7 and human BCMs 3 to 9 were searched. Bovine BCMs 3, 4, 6 and 7 were found in the undigested fortifiers. Following in vitro digestion simulating the digestive conditions of premature infant, bovine BCMs still occurred in fortified PDHM; the human BCMs 3, 7, 8 and 9 formed. Overall, these results better address the nutritional features of protein fortifiers and fortified PDHM intended for nutrition of preterm infants.


Subject(s)
Endorphins/analysis , Food, Fortified , Milk Proteins/chemistry , Milk, Human/chemistry , Animals , Cattle , Digestion , Endorphins/chemistry , Female , Food, Fortified/analysis , Hot Temperature , Humans , Infant Nutritional Physiological Phenomena , Infant, Newborn , Infant, Premature , Lysine/analogs & derivatives , Lysine/analysis , Lysinoalanine/analysis , Norleucine/analogs & derivatives , Norleucine/analysis , Pasteurization , Pyrroles/analysis
5.
Toxicon ; 163: 48-58, 2019 May.
Article in English | MEDLINE | ID: mdl-30880189

ABSTRACT

Indospicine is a natural toxin occurring only in Indigofera plant species, including the Australian native species I. linnaei. These perennial legumes are resistant to drought and palatable to grazing livestock including cattle. Indospicine accumulates in the tissues (including muscle) of animals grazing Indigofera and these residues persist for several months after exposure. Dogs are particularly sensitive to indospicine with reports in past decades of hepatotoxicosis and mortalities in dogs after dietary exposure to indospicine-contaminated horse and camel meat. The risk for human consumption is not known, and the current study was undertaken to assess indospicine levels in cattle going to slaughter from divergent regions of Western Australia, and to predict the likelihood of significant residues being present. Muscle and corresponding liver samples from 776 cattle originating from the Kimberley and Pilbara Regions in the tropical north of the state, where I. linnaei is prevalent, and 640 cattle from the South West and South Coast Regions in the temperate south west of the state, where the plant is not known to occur, were collected at abattoirs over four seasons in 2015-2017. Indospicine levels were measured by LC-MS/MS and ranged from below detection to 3.63 mg/kg. No indospicine residues were detected in any of the animals originating from the South West and South Coast Regions. Prevalence of indospicine residues in cattle from the Kimberley Region was as high as 33% in spring and 91% in autumn, with positive animals being present in most consignments and on most properties. The average prevalence of indospicine residues from the Kimberley and Pilbara Regions throughout the survey period was 63%. @Risk best fit probability distributions showed ninety-fifth percentile (P95) indospicine concentrations of 0.54 mg/kg for muscle and 0.77 mg/kg for liver in cattle originating from the Kimberley and Pilbara Regions during the survey period. When considered with average Australian meat consumption data, the estimated consumer exposure from this P95 muscle was 0.32 µg indospicine/kg bw/day, which compared favourably with our calculated provisional tolerable daily intake (PTDI) of 1.3 µg indospicine/kg bw/day. However canine exposure is of potential concern, with active working dog exposure calculated to exceed this PTDI by a factor of 25, based on a P95 indospicine concentration of 0.54 mg/kg in muscle.


Subject(s)
Cattle , Liver/chemistry , Muscle, Skeletal/chemistry , Norleucine/analogs & derivatives , Animals , Diet/veterinary , Dogs , Food Contamination/analysis , Humans , Indigofera , Norleucine/analysis , Norleucine/toxicity , Plants, Toxic , Red Meat/analysis , Risk Assessment , Seasons , Toxins, Biological/analysis , Western Australia
6.
J Clin Invest ; 52(10): 2571-8, 1973 Oct.
Article in English | MEDLINE | ID: mdl-4729050

ABSTRACT

The biochemical mechanism accounting for the connective tissue abnormalities in homocystinuria was explored by examining the effects of various amino acids known to accumulate in the plasma of patients with this disease on cross-link formation in collagen. Neutral salt solutions of purified, rat skin collagen, rich in cross-link precursor aldehydes, were polymerized to native type fibrils by incubating at 37 degrees C in the presence of homocysteine, homocystine, or methionine. After the polymerization was completed, each sample was examined for the formation of covalent intermolecular cross-links, assessed indirectly by solubility tests and directly by measuring the cross-link compounds after reduction with tritiated sodium borohydride and hydrolysis. Collagen solutions containing homocysteine (0.01 M-0.1 M) failed to form insoluble fibrils. Furthermore, much less of the reducible cross-links, Delta(6,7) dehydrohydroxylysinonorleucine, Delta(6,7) dehydrohydroxylysinohydroxynorleucine, and histidino-dehydrohydroxymerodesmosine were formed in the preparations containing homocysteine as compared with the control and the samples containing methionine or homocystine. The content of the precursor aldehydes, alpha-aminoadipic-delta-semialdehyde (allysine) and the aldol condensation product, was also markedly diminished in tropocollagen incubated with homocysteine. It is concluded that homocysteine interferes with the formation of intermolecular cross-links that help stabilize the collagen macromolecular network via its reversible binding to the aldehydic functional groups. Analysis of the collagen cross-links in skin biopsy samples obtained from three patients with documented homocystinuria showed that the cross-links were significantly decreased as compared with the age-matched controls, supporting the tentative conclusions reached from the in vitro model studies. In addition, the solubility of dermal collagen in non-denaturing solvents was significantly increased in the two patients examined, reflecting a functional defect in collagen cross-linking. Although the concentration of homocysteine used in this study to demonstrate these effects in vitro is clearly higher than that which is observed in homocystinuric's plasma, the data do suggest a possible pathogenetic mechanism of connective tissue defect in homocystinuria.


Subject(s)
Collagen/metabolism , Homocystinuria/metabolism , Adult , Aldehydes/metabolism , Amino Acids/analysis , Biopsy , Borohydrides , Child , Collagen/analysis , Dialysis , Histidine/analysis , Homocysteine/pharmacology , Homocystine/pharmacology , Humans , Hydrolysis , Hydroxylysine/analysis , Methionine/pharmacology , Microscopy, Electron , Norleucine/analysis , Skin/analysis , Sodium , Solubility , Temperature , Time Factors , Tritium
7.
J Agric Food Chem ; 65(4): 986-992, 2017 Feb 01.
Article in English | MEDLINE | ID: mdl-28081599

ABSTRACT

A novel core-shell metal-organic framework coated with a dummy template molecularly imprinted polymer (MOF@DMIP) was synthesized by one-pot bulk polymerization for the detection of pyrraline in food samples. The pyrraline analogue pyrrolidine-3-carboxylic acid was used as the template because of its lower cost, and MIL-101 was used as the MOF core owing to its numerous inherent advantages, including high chemical and hydrothermal stabilities. MIL-101@DMIP was used to detect trace pyrraline in foods by solid-phase extraction combined with high-performance liquid chromatography. It exhibited the advantages of faster mass transport, excellent sensitivity, and selectivity. Under optimum conditions, the detection limit of this system was 40.7 µg L-1, and a linear range was from 5 × 10-7 to 2 × 10-3 mol L-1, within relative standard deviations of 4.46-6.87%. The recoveries ranged from 92.23 to 103.87%, indicating the excellent ability of the prepared MIL-101@DMIP to recognize pyrraline in complex food matrices and its potential for application in pyrraline detection.


Subject(s)
Food Contamination/analysis , Milk/chemistry , Nanoparticles/chemistry , Norleucine/analogs & derivatives , Polymers/chemistry , Pyrroles/isolation & purification , Solid Phase Extraction/methods , Adsorption , Animals , Cattle , Limit of Detection , Molecular Imprinting , Norleucine/analysis , Norleucine/isolation & purification , Polymers/chemical synthesis , Powders/chemistry , Pyrroles/analysis , Solid Phase Extraction/instrumentation
8.
Article in English | MEDLINE | ID: mdl-27575484

ABSTRACT

Camel meat production for human consumption and pet food manufacture accounts for a relatively small part of overall red meat production in Australia. Reliable statistical data for the Australian production and consumption of camel meat are not available; however, it is estimated that 300,000 feral camels roam within the desert of central Australia, with an annual usage of more than 3000 camels for human consumption, 2000 for pet food manufacture and a smaller number for live export. Despite a small Australian camel meat production level, the usage of camel meat for pet food has been restricted in recent years due to reports of serious liver disease and death in dogs consuming camel meat. This camel meat was found to contain residues of indospicine, a non-proteinogenic amino acid found in certain Indigofera spp., and associated with mild to severe liver disease in diverse animals after dietary exposure to this hepatotoxin. The extent of indospicine-contaminated Australian camel meat was previously unknown, and this study ascertains the prevalence of such residue in Australian camel meat. In this study, indospicine levels in ex situ (95 samples collected from an abattoir in Queensland) and in situ (197 samples collected from camels after field culling in central Australia) camel meat samples were quantitated using a validated ultra-performance liquid chromatography-tandem mass spectrometry (UPLC-MS/MS). The quantitation results showed 46.7% of the in situ- and 20.0% of the ex situ-collected camel meat samples were contaminated by indospicine (more than the limit of detection (LOD) of 0.05 mg kg-1 fresh weight). The overall indospicine concentration was higher (p < 0.05) in the in situ-collected samples. Indospicine levels detected in the present study are considered to be low; however, a degree of caution must still be exercised, since the tolerable daily intake for indospicine is currently not available for risk estimation.


Subject(s)
Biological Products/analysis , Camelus , Food Contamination/analysis , Meat/analysis , Norleucine/analogs & derivatives , Animals , Australia , Chromatography, High Pressure Liquid , Female , Male , Norleucine/analysis , Tandem Mass Spectrometry
9.
J Agric Food Chem ; 64(34): 6613-21, 2016 Aug 31.
Article in English | MEDLINE | ID: mdl-27509381

ABSTRACT

Livestock industries have maintained a keen interest in pasture legumes because of the high protein content and nutritive value. Leguminous Indigofera plant species have been considered as having high feeding values to be utilized as pasture, but the occurrence of the toxic constituent indospicine in some species has restricted this utility. Indospicine has caused both primary and secondary hepatotoxicosis and also reproductive losses, but has only previously been determined in a small number of Indigofera species. This paper validates a high-throughput ultraperformance liquid chromatography-tandem mass spectrometry (UPLC-MS/MS) method to determine the indospicine content of various Indigofera species found in Australian pasture. Twelve species of Indigofera together with Indigastrum parviflorum plants were collected and analyzed. Of the 84 samples analyzed, *I. spicata (the asterisk indicates a naturalized species) contained the highest indospicine level (1003 ± 328 mg/kg DM, n = 4) followed by I. linnaei (755 ± 490 mg/kg DM, n = 51). Indospicine was not detected in 9 of the remaining 11 species and at only low levels (<10 mg/kg DM) in 2 of 8 I. colutea specimens and in 1 of 5 I. linifolia specimens. Indospicine concentrations were below quantitation levels for other Indigofera spp. (I. adesmiifolia, I. georgei, I. hirsuta, I. leucotricha, *I. oblongifolia, I. australis, and I. trita) and Indigastrum parviflorum. One of the more significant findings to emerge from this study is that the indospicine content of I. linnaei is highly variable (from 159 to 2128 mg/kg DM, n = 51) and differs across both regions and seasons. Its first regrowth after spring rain has a higher (p < 0.01) indospicine content than growth following more substantial summer rain. The species collected include the predominant Indigofera in Australia pasture, and of these, only *I. spicata and I. linnaei contain high enough levels of indospicine to pose a potential toxic threat to grazing herbivores.


Subject(s)
Indigofera/chemistry , Norleucine/analogs & derivatives , Toxins, Biological/analysis , Australia , Chromatography, High Pressure Liquid , Indigofera/toxicity , Norleucine/analysis , Seasons , Tandem Mass Spectrometry
10.
J Agric Food Chem ; 64(44): 8447-8453, 2016 Nov 09.
Article in English | MEDLINE | ID: mdl-27737547

ABSTRACT

Ingestion of indospicine-contaminated camel and horse meat has caused fatal liver injury to dogs in Australia, and it is currently not known if such contaminated meat may pose a human health risk upon dietary exposure. To date, indospicine-related research has tended to focus on analytical aspects, with little information on post-harvest management of indospicine-contaminated meat. In this study, indospicine degradation was investigated in both aqueous solution and also contaminated meat, under a range of conditions. Aqueous solutions of indospicine and indospicine-contaminated camel meat were microwaved (180 °C) or autoclaved (121 °C) with the addition of food-grade additives [0.05% (v/v) acetic acid or 0.05% (w/v) sodium bicarbonate] for 0, 15, 30, and 60 min. An aqueous sodium bicarbonate solution demonstrated the greatest efficacy in degrading indospicine, with complete degradation after 15 min of heating in a microwave or autoclave; concomitant formation of indospicine degradation products, namely, 2-aminopimelamic and 2-aminopimelic acids, was observed. Similar treatment of indospicine-contaminated camel meat with aqueous sodium bicarbonate resulted in 50% degradation after 15 min of heating in an autoclave and 100% degradation after 15 min of heating in a microwave. The results suggest that thermo-alkaline aqueous treatment has potential as a pragmatic post-harvest handling technique in reducing indospicine levels in indospicine-contaminated meat.


Subject(s)
Camelus , Food Contamination , Meat , Norleucine/analogs & derivatives , Amino Acids, Neutral/analysis , Animals , Chromatography, Liquid/methods , Hydrolysis , Mass Spectrometry/methods , Norleucine/analysis , Norleucine/chemistry , Pimelic Acids/analysis , Sodium Bicarbonate/chemistry
11.
J Agric Food Chem ; 64(38): 7234-43, 2016 Sep 28.
Article in English | MEDLINE | ID: mdl-27594145

ABSTRACT

The Maillard reaction is important for beer color and flavor, but little is known about the occurrence of individual glycated amino acids in beer. Therefore, seven Maillard reaction products (MRPs), namely, fructosyllysine, maltulosyllysine, pyrraline, formyline, maltosine, MG-H1, and argpyrimidine, were synthesized and quantitated in different types of beer (Pilsner, dark, bock, wheat, and nonalcoholic beers) by HPLC-ESI-MS/MS in the multiple reaction monitoring mode through application of the standard addition method. Free MRPs were analyzed directly. A high molecular weight fraction was isolated by dialysis and hydrolyzed enzymatically prior to analysis. Maltulosyllysine was quantitated for the first time in food. The most important free MRPs in beer are fructosyllysine (6.8-27.0 mg/L) and maltulosyllysine (3.7-21.8 mg/L). Beer contains comparatively high amounts of late-stage free MRPs such as pyrraline (0.2-1.6 mg/L) and MG-H1 (0.3-2.5 mg/L). Minor amounts of formyline (4-230 µg/L), maltosine (6-56 µg/L), and argpyrimidine (0.1-4.1 µg/L) were quantitated. Maltulosyllysine was the most significant protein-bound MRP, but both maltulosyllysine and fructosyllysine represent only 15-60% of the total protein-bound lysine-derived Amadori products. Differences in the patterns of protein-bound and free individual MRPs and the ratios between them were identified, which indicate differences in their chemical, biochemical, and microbiological stabilities during the brewing process.


Subject(s)
Beer/analysis , Food Handling , Maillard Reaction , Amino Acids/analysis , Lysine/analogs & derivatives , Lysine/analysis , Norleucine/analogs & derivatives , Norleucine/analysis , Ornithine/analogs & derivatives , Ornithine/analysis , Pyridones/analysis , Pyrimidines/analysis , Pyrroles/analysis , Tandem Mass Spectrometry
12.
J Biotechnol ; 235: 100-11, 2016 Oct 10.
Article in English | MEDLINE | ID: mdl-27107466

ABSTRACT

The residue-specific labeling of proteins with non-canonical amino acids (ncAA) is well established in shake flask cultures. A key aspect for the transfer of the methodology to larger scales for biotechnological applications is the cost of the supplemented ncAAs. Therefore, we established a scalable bioprocess using an engineered host strain for the biosynthesis of the methionine analog norleucine at titers appropriate for the efficient and economic labeling of proteins. To enhance the biosynthesis of norleucine, which is a side-product of the branched chain amino acid pathway, we deleted all three acetolactate synthase isoforms of the methionine auxotrophic Escherichia coli expression strain B834(DE3). Additionally, we overexpressed leuABCD to boost the biosynthesis of norleucine. We systematically analyzed the production of norleucine under the conditions for its residue-specific incorporation in bioreactor cultures that had a 30-fold higher cell density than shake flask cultures. Under optimized conditions, 5g/L norleucine was biosynthesized. This titer is two times higher than the standard supplementation with norleucine of a culture with comparable cell density. We expect that our metabolically engineered strain for the improved biosynthesis of norleucine in combination with the proposed bioprocess will facilitate the efficient residue-specific labeling of proteins at a reasonable price in scales beyond the shake flask.


Subject(s)
Escherichia coli/metabolism , Metabolic Engineering/methods , Norleucine , Recombinant Proteins , Acetolactate Synthase/metabolism , Escherichia coli/genetics , Norleucine/analysis , Norleucine/chemistry , Norleucine/metabolism , Recombinant Proteins/analysis , Recombinant Proteins/chemistry , Recombinant Proteins/isolation & purification , Recombinant Proteins/metabolism
13.
Biochim Biophys Acta ; 492(2): 408-14, 1977 Jun 24.
Article in English | MEDLINE | ID: mdl-884139

ABSTRACT

The changes in solubility and amounts of reducible cross-links have been studied during "ageing" in vitro of reprecipitated rat skin collagen fibres by incubation at 37 degrees C. Fibres from pre-reduced collagen devoid of aldehyde precursors became insoluble at the same rate as that of normal fibres during "ageing". Insolubilization occurred at a much faster rate in the presence of oxygen than in air and was almost completely inhibited when oxygen was excluded. The rate of decline of the reducible cross-links was, however, unaffected by oxygen tension. The results indicate that, during "ageing" in vitro, conversion of the lysine-derived cross-links to a non-reducible form is not associated with solubility changes. The relationship of these in vitro changes to those ocurring in vivo is unknown.


Subject(s)
Collagen , Animals , Bone and Bones , Cattle , Chemical Precipitation , Drug Stability , Hydroxylysine/analysis , Kinetics , Macromolecular Substances , Norleucine/analysis , Protein Binding , Rats , Skin , Solubility , Time Factors
14.
Food Chem ; 188: 286-93, 2015 Dec 01.
Article in English | MEDLINE | ID: mdl-26041194

ABSTRACT

The effect of processing conditions on heat damage, starch digestibility, release of advanced glycation end products (AGEs) and antioxidant capacity of puffed cereals was studied. The determination of several markers arising from Maillard reaction proved pyrraline (PYR) and hydroxymethylfurfural (HMF) as the most reliable indices of heat load applied during puffing. The considerable heat load was evidenced by the high levels of both PYR (57.6-153.4 mg kg(-1) dry matter) and HMF (13-51.2 mg kg(-1) dry matter). For cost and simplicity, HMF looked like the most appropriate index in puffed cereals. Puffing influenced starch in vitro digestibility, being most of the starch (81-93%) hydrolyzed to maltotriose, maltose and glucose whereas only limited amounts of AGEs were released. The relevant antioxidant capacity revealed by digested puffed kernels can be ascribed to both the new formed Maillard reaction products and the conditions adopted during in vitro digestion.


Subject(s)
Food Handling/methods , Hot Temperature , Starch/chemistry , Triticum/chemistry , Antioxidants/analysis , Chemical Phenomena , Edible Grain/chemistry , Furaldehyde/analogs & derivatives , Furaldehyde/analysis , Glucose/chemistry , Hydrolysis , Maillard Reaction , Maltose/chemistry , Models, Biological , Norleucine/analogs & derivatives , Norleucine/analysis , Pyrroles/analysis , Trisaccharides/chemistry
15.
PLoS One ; 10(12): e0145451, 2015.
Article in English | MEDLINE | ID: mdl-26690742

ABSTRACT

The ability of the nervous system to undergo long-term plasticity is based on changes in cellular and synaptic proteomes. While many studies have explored dynamic alterations in neuronal proteomes during plasticity, there has been less attention paid to the astrocytic counterpart. Indeed, progress in identifying cell type-specific proteomes is limited owing to technical difficulties. Here, we present a cell type-specific metabolic tagging technique for a mammalian coculture model based on the bioorthogonal amino acid azidonorleucine and the mutated Mus musculus methionyl-tRNA synthetaseL274G enabling azidonorleucine introduction into de novo synthesized proteins. Azidonorleucine incorporation resulted in cell type-specific protein labeling and retained neuronal or astrocytic cell viability. Furthermore, we were able to label astrocytic de novo synthesized proteins and identified both Connexin-43 and 60S ribosomal protein L10a upregulated upon treatment with Brain-derived neurotrophic factor in astrocytes of a neuron-glia coculture. Taken together, we demonstrate the successful dissociation of astrocytic from neuronal proteomes by cell type-specific metabolic labeling offering new possibilities for the analyses of cell type-specific proteome dynamics.


Subject(s)
Astrocytes/metabolism , Alanine/analogs & derivatives , Alanine/chemistry , Animals , Astrocytes/cytology , Astrocytes/drug effects , Azides/analysis , Azides/chemistry , Brain-Derived Neurotrophic Factor/pharmacology , Coculture Techniques , Green Fluorescent Proteins/genetics , Green Fluorescent Proteins/metabolism , HEK293 Cells , Humans , Methionine-tRNA Ligase/genetics , Methionine-tRNA Ligase/metabolism , Neuroglia/cytology , Norleucine/analogs & derivatives , Norleucine/analysis , Norleucine/chemistry , Protein Biosynthesis , Proteins/chemistry , Proteins/metabolism , Proteome , Proteomics/methods , Rats, Wistar
16.
Invest Ophthalmol Vis Sci ; 17(1): 63-5, 1978 Jan.
Article in English | MEDLINE | ID: mdl-621128

ABSTRACT

The examination of reducible collagen crosslinks in keratoconus cornea revealed the presence of lysinonorleucine in amounts far greater than in normal age-matched corneas. There was no indication of decreased hydroxylysine levels in keratoconus, and there were no clinical indications of a generalized connective tissue disorder. The abnormal levels of dehydrolysinonorleucine in the tissue may represent a change in hydroxylation of selected lysyl residues of normal collagen or the synthesis of abnormal collagen, perhaps an unusual type.


Subject(s)
Collagen/analysis , Cornea/analysis , Keratoconus/metabolism , Adult , Collagen/biosynthesis , Female , Humans , Lysine/analysis , Male , Middle Aged , Norleucine/analysis
17.
J Clin Pathol ; 28(4): 305-8, 1975 Apr.
Article in English | MEDLINE | ID: mdl-1127123

ABSTRACT

The crosslink in bone collagen was analysed in specimens of bone obtained at necropsy from cases of Paget's disease and compared with normal bone collagen of the same age. The specimens were stored at -20 degrees C before analysis. The predominant crosslink in a normal bone collagen was hydroxylysinohydroxynorleucine (di OH-LNL) (F1), which was designated syndesine in the past; another fraction, hydroxylysinorleucine (HLNL) (F2), musch less prominent than di OH-LNL, was also noted in a normal bone collagen. Both fractions were reduced in bone tissue of advancing age. The peak corresponding to HLNL was considerably increased in Paget's disease. This abnormality was constantly seen in specimens of bone from cases of Paget's disease, but the significance of the finging could not be assessed from the present investigation. Calcitonin has been shown to produce complete remission in Paget's disease and the crosslink pattern was found to be normal in specimens examined froma calcitonin-treated patient. This shows that calcitonin has some effect on the metabolism of collagen and a normal crosslink in such a situation lends support to this idea.


Subject(s)
Collagen/analysis , Osteitis Deformans/metabolism , Adolescent , Adult , Age Factors , Aged , Binding Sites , Calcitonin/therapeutic use , Chemical Phenomena , Chemistry , Collagen/metabolism , Female , Humans , Male , Middle Aged , Norleucine/analogs & derivatives , Norleucine/analysis , Osteitis Deformans/drug therapy , Tritium
18.
Urology ; 50(6): 1016-26, 1997 Dec.
Article in English | MEDLINE | ID: mdl-9426743

ABSTRACT

OBJECTIVES: We hypothesized that advanced glycation end product (AGE) formation contributes to erectile dysfunction (ED) by quenching nitric oxide. Our first goal was to identify the specific AGE pentosidine in the diabetic human penis. Because AGE-mediated effects may involve inducible nitric oxide synthase (iNOS), we performed immunohistochemical and Western blot analysis of diabetic and nondiabetic human penile tissue for iNOS. Finally, because AGEs may act intracellularly to affect proteins, we set out to identify endothelial NOS (eNOS) in the human penis as an initial step in examining a possible intracellular interaction between eNOS and AGEs. METHODS: We performed high-performance liquid chromatographic analysis of diabetic human penile corpus cavernosum and serum for pentosidine and performed immunohistochemical, electron microscopic (EM), and Western blot analysis of the diabetic and nondiabetic penile corpus cavernosum and tunica for pyrraline, iNOS, and eNOS (and neural NOS [nNOS] for comparative purposes) via standard methods. RESULTS: We found a significant elevation of pentosidine in the penile tissue but not the serum of diabetic patients (average age 55.6 +/- 2.3 years) compared with that of nondiabetic patients (average age 61.8 +/- 3.6 years). Pentosidine was 117.06 +/- 9.19 pmol/mg collagen in the diabetic tunica versus 77.58 +/- 5.5 pmol/mg collagen in the nondiabetic tunica (P < 0.01) and 74.58 +/- 8.49 pmol/mg collagen in the diabetic corpus cavernosum versus 46.59 +/- 2.53 pmol/mg collagen in the nondiabetic corpus cavernosum (P < 0.01), suggesting a tissue-specific effect of the AGEs. We localized the site of deposition of the specific AGE pyrraline to the human penile tunica and the penile corpus cavernosum collagen. Immunohistochemical and EM analysis localized eNOS and iNOS to the cavernosal endothelium and smooth muscle. Western blot analysis in 6 patients revealed the following: iNOS, but no eNOS, in penile tissue from 1 insulin-dependent diabetic man; eNOS only in 1 man after radical prostatectomy; both eNOS and iNOS in 2 men with Peyronie's disease, as well as in 2 other men with impotence and hypertension. Finally, the specific iNOS inhibitor PNU-19451A significantly augmented relaxation of precontracted human cavernosal tissue, from 64.7% +/- 5.58 to 80.03% +/- 4.55 at 10 microM acetylcholine and 65.06% +/- 2.84 to 86.16% +/- 3.96 at 0.1 mM acetylcholine (n = 4, P < 0.002 and P < 0.02, respectively). CONCLUSIONS: AGEs are elevated in diabetic human penile tissue, but not in serum, and are localized to the collagen of the penile tunica and corpus cavernosum. We identified eNOS and iNOS in the human penile cavernosal smooth muscle and endothelium. The augmentation of cavernosal relaxation with a specific iNOS inhibitor, combined with the identification of iNOS protein, but not eNOS, in a patient with severe diabetes and ED, allows for speculation of a pathophysiologic mechanism for AGE-mediated ED via upregulation of iNOS and downregulation of eNOS. These data provide further insight into the mechanisms of advanced glycation end product-mediated ED and provide a foundation for further study.


Subject(s)
Diabetes Mellitus, Type 1/metabolism , Diabetes Mellitus, Type 2/metabolism , Glycation End Products, Advanced/metabolism , Nitric Oxide Synthase/biosynthesis , Penis/metabolism , Adult , Aged , Arginine/analogs & derivatives , Arginine/analysis , Arginine/metabolism , Blotting, Western/methods , Chromatography, High Pressure Liquid , Cross-Linking Reagents/analysis , Cross-Linking Reagents/metabolism , Diabetes Mellitus, Type 1/pathology , Diabetes Mellitus, Type 2/pathology , Electron Probe Microanalysis/methods , Endothelium/chemistry , Endothelium/metabolism , Enzyme Induction , Erectile Dysfunction/metabolism , Erectile Dysfunction/pathology , Glycation End Products, Advanced/analysis , Humans , Immunohistochemistry , Lysine/analogs & derivatives , Lysine/analysis , Lysine/metabolism , Male , Middle Aged , Nitric Oxide Synthase/analysis , Nitric Oxide Synthase Type II , Nitric Oxide Synthase Type III , Norleucine/analogs & derivatives , Norleucine/analysis , Norleucine/metabolism , Penis/ultrastructure , Pyrroles/analysis , Pyrroles/metabolism
19.
Brain Res ; 737(1-2): 195-200, 1996 Oct 21.
Article in English | MEDLINE | ID: mdl-8930366

ABSTRACT

Oxidative stress is well accepted as an important pathogenic factor in Parkinson disease, based largely on indirect evidence. Recently, we have developed antibodies that recognize specific advanced glycation end-products (anti-pentosidine and anti-pyrraline), protein modifications that are potentiated by oxidative stress in a process termed glycoxidation. We applied these antibodies immunocytochemically to affected regions in Parkinson disease and diffuse Lewy body disease brains. Additionally, we used antibodies to heme oxygenase-1, a putative marker of oxidative stress response. Immunoreactivity to pentosidine, pyrraline, and heme oxygenase-1 was seen in the substantia nigra of Parkinson disease and the neocortex of diffuse Lewy body disease. Heme oxygenase-1 was further demonstrated by immunoelectron microscopy in intimate association with filaments of cortical Lewy bodies. Immunolocalization of advanced glycation end-products and a marker of oxidative stress response induction provides evidence that glycoxidation and oxidative stress may be an important pathogenic factor in diseases characterized by Lewy body formation, and furthers the evidence that cytoskeletal proteins and their inclusions are susceptible to oxidative stress.


Subject(s)
Oxidative Stress/physiology , Parkinson Disease/metabolism , Aged , Aged, 80 and over , Arginine/analogs & derivatives , Arginine/analysis , Cerebral Cortex/chemistry , Cerebral Cortex/enzymology , Cross-Linking Reagents/analysis , Glycation End Products, Advanced/metabolism , Glycosylation , Heme Oxygenase (Decyclizing)/analysis , Humans , Immunohistochemistry , Locus Coeruleus/chemistry , Locus Coeruleus/enzymology , Lysine/analogs & derivatives , Lysine/analysis , Microscopy, Immunoelectron , Middle Aged , Neurons/chemistry , Neurons/enzymology , Neurons/ultrastructure , Norleucine/analogs & derivatives , Norleucine/analysis , Parkinson Disease/physiopathology , Pyrroles/analysis , Substantia Nigra/chemistry , Substantia Nigra/enzymology
20.
Neurosci Lett ; 231(2): 79-82, 1997 Aug 08.
Article in English | MEDLINE | ID: mdl-9291145

ABSTRACT

Rosenthal fibers, astrocytic inclusions that accumulate in various neoplastic and non-neoplastic conditions, are a characteristic of Alexander disease, a leukodystrophy of unknown etiology. Given that alphaB crystallin is the major protein component of Rosenthal fibers and that crystallins in the diabetic and aged lens are targets for advanced glycation end product modifications via the Maillard reaction we hypothesized that Rosenthal fibers might contain similar modifications. Using antibodies specific for two products of glycation, pyrraline and pentosidine, we showed labeling of Rosenthal fibers that may account for their insolubility and accumulation. These data suggest that advanced glycation end products may be critical to the pathogenesis of Alexander disease.


Subject(s)
Astrocytes/pathology , Brain Diseases/pathology , Demyelinating Diseases/pathology , Glycation End Products, Advanced/metabolism , Inclusion Bodies/pathology , Adolescent , Arginine/analogs & derivatives , Arginine/analysis , Astrocytes/chemistry , Brain Diseases/metabolism , Child , Cross-Linking Reagents/analysis , Crystallins/analysis , Demyelinating Diseases/metabolism , Humans , Lysine/analogs & derivatives , Lysine/analysis , Norleucine/analogs & derivatives , Norleucine/analysis , Pyrroles/analysis
SELECTION OF CITATIONS
SEARCH DETAIL